publisher
WordPress 622date published
Friday September 3rd, 2021
authors
Stanford University, Taylor Kubota
summary
Bioengineers have repurposed a “non-working” CRISPR system to make a smaller version of the genome engineering tool. Its diminutive size should make it easier to deliver into human cells, tissues and the body for gene therapy.